Self-Measurement of Blood Pressure at Home Reduces the Need for Antihypertensive Drugs
Authors:
- Willem J VerberkWVWillem J Verberk
- Abraham A KroonAKAbraham A Kroon
- Jacques W M LendersJLJacques W M Lenders
- Alfons G H KesselsAKAlfons G H Kessels
- Gert A Van MontfransGMGert A Van Montfrans
- Andries J SmitASAndries J Smit
- Paul-Hugo M Van Der KuyPKPaul-Hugo M Van Der Kuy
- Patricia J NelemansPNPatricia J Nelemans
- Roger J M W RennenbergRRRoger J M W Rennenberg
- Diederick E GrobbeeDGDiederick E Grobbee
- Frank W BeltmanFBFrank W Beltman
- Manuela A JooreMJManuela A Joore
- 1 December 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 50 (6) , 1019-1025
Abstract
It is still uncertain whether one can safely base treatment decisions on self-measurement of blood pressure. In the present study, we investigated whether antihypertensive treatment based on self-measurement of blood pressure leads to the use of less medication without the loss of blood pressure control. We randomly assigned 430 hypertensive patients to receive treatment either on the basis of self-measured pressures (n=216) or office pressures (OPs; n=214). During 1-year follow-up, blood pressure was measured by office measurement (10 visits), ambulatory monitoring (start and end), and self-measurement (8 times, self-pressure group only). In addition, drug use, associated costs, and degree of target organ damage (echocardiography and microalbuminuria) were assessed. The self-pressure group used less medication than the OP group (1.47 versus 2.48 drug steps; P P P =0.25/0.20), in changes in left ventricular mass index (−6.5 g/m 2 versus −5.6 g/m 2 ; P =0.72), or in median urinary microalbumin concentration (−1.7 versus −1.5 mg per 24 hours; P =0.87). Nevertheless, 24-hour ambulatory blood pressure values at the end of the trial were higher in the self-pressure than in the OP group: 125.9 versus 123.8 mm Hg ( P P <0.05) for diastolic blood pressure. These data show that self-measurement leads to less medication use than office blood pressure measurement without leading to significant differences in OP values or target organ damage. Ambulatory values, however, remain slightly elevated for the self-pressure group.Keywords
This publication has 29 references indexed in Scilit:
- Comparison of randomization techniques for clinical trials with data from the HOMERUS‐trialBlood Pressure, 2005
- White coat effect in treated versus untreated hypertensive individuals: a case-control study using ambulatory and home blood pressure monitoringAmerican Journal of Hypertension, 2004
- Clinical Implication of Morning Blood Pressure Surge in HypertensionJournal of Cardiovascular Pharmacology, 2003
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Left ventricular hypertrophy in treated hypertensive patients with good blood pressure control outside the clinic, but poor clinic blood pressure controlJournal Of Hypertension, 2003
- Home versus office blood pressure MEasurements: reduction of unnecessary treatment study: rationale and study design of the HOMERUS trialBlood Pressure, 2003
- What is the white-coat effect and how should it be measured?Blood Pressure Monitoring, 2002
- Value of Home Blood Pressures as Predictor of Target Organ Damage in Mild Arterial HypertensionEuropean Journal of Preventive Cardiology, 2002
- Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurementJournal Of Hypertension, 1998
- Antihypertensive Treatment Based on Conventional or Ambulatory Blood Pressure MeasurementJAMA, 1997